- Corporate Officers - B
- Berns Paul L
Insider Trading History of Berns Paul L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Berns Paul L since 2006.
This trader's CIK number is 1202769.
At the time of last reporting, Berns Paul L was the See Remarks of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA).
Also see all insider trading activities at Neumora Therapeutics, Inc..
Note that in the past
BERNS PAUL L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Neumora Therapeutics, Inc. (NMRA) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | NMRA | 0 | $0 | 13,871 | $23,469 | 0 | $0 |
Yearly summary of insider trading at Metsera, Inc. (MTSR) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | MTSR | 789,998 | $14,219,964 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Xenoport Inc (XNPT) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | XNPT | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2015 | XNPT | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2014 | XNPT | 0 | $0 | 5,000 | $19,900 | 5,000 | $0 |
| 2013 | XNPT | 0 | $0 | 0 | $0 | 5,000 | $0 |
| 2008 | XNPT | 0 | $0 | 12,500 | $525,600 | 12,500 | $160,750 |
Yearly summary of insider trading at Anacor Pharmaceuticals Inc (ANAC) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ANAC | 0 | $0 | 40,033 | $2,540,423 | 0 | $0 |
| 2015 | ANAC | 0 | $0 | 147,500 | $13,182,627 | 60,000 | $469,400 |
| 2014 | ANAC | 0 | $0 | 25,000 | $770,500 | 0 | $0 |
Yearly summary of insider trading at Allos Therapeutics Inc (ALTH) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | ALTH | 0 | $0 | 56,145 | $84,993 | 0 | $0 |
| 2011 | ALTH | 0 | $0 | 45,715 | $90,328 | 2,500 | $7,850 |
| 2010 | ALTH | 0 | $0 | 109,406 | $772,310 | 0 | $0 |
| 2009 | ALTH | 0 | $0 | 350,000 | $2,884,600 | 350,000 | $1,099,000 |
| 2008 | ALTH | 5,000 | $19,465 | 34,400 | $185,106 | 0 | $0 |
| 2007 | ALTH | 2,500 | $7,627 | 23,625 | $152,452 | 0 | $0 |
| 2006 | ALTH | 5,000 | $14,700 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Jazz Pharmaceuticals Plc (JAZZ) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | JAZZ | 0 | $0 | 1,450 | $223,300 | 0 | $0 |
| 2020 | JAZZ | 0 | $0 | 5,622 | $817,105 | 4,691 | $0 |
| 2019 | JAZZ | 0 | $0 | 726 | $98,481 | 0 | $0 |
| 2018 | JAZZ | 0 | $0 | 660 | $116,563 | 0 | $0 |
| 2017 | JAZZ | 0 | $0 | 662 | $94,828 | 0 | $0 |
| 2016 | JAZZ | 0 | $0 | 633 | $86,372 | 0 | $0 |
| 2015 | JAZZ | 0 | $0 | 801 | $145,518 | 0 | $0 |
| 2014 | JAZZ | 0 | $0 | 1,087 | $144,734 | 0 | $0 |
| 2013 | JAZZ | 0 | $0 | 1,070 | $87,590 | 0 | $0 |
| 2012 | JAZZ | 0 | $0 | 39,200 | $1,942,752 | 55,000 | $931,535 |
Yearly summary of insider trading at Cellectar Biosciences, Inc. (CLRB) by Berns Paul L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | CLRB | 117,371 | $248,826 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Berns Paul L:
1. Neumora Therapeutics, Inc. (NMRA)
2. Metsera, Inc. (MTSR)
3. Xenoport Inc (XNPT)
4. Anacor Pharmaceuticals Inc (ANAC)
5. Allos Therapeutics Inc (ALTH)
6. Jazz Pharmaceuticals Plc (JAZZ)
7. Cellectar Biosciences, Inc. (CLRB)
Table 1. Insider trading of Neumora Therapeutics, Inc. (NMRA) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-18 | NMRA | Sale | 13,871 | 1.69 | 23,469 |
Table 2. Insider trading of Metsera, Inc. (MTSR) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-03 | MTSR | Buy | 789,998 | 18.00 | 14,219,964 |
Table 3. Insider trading of Xenoport Inc (XNPT) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-05-17 | XNPT | Option Ex | 5,000 | .00 | 0 |
| 2015-05-19 | XNPT | Option Ex | 5,000 | .00 | 0 |
| 2014-05-15 | XNPT | Sale | 2,500 | 3.66 | 9,150 |
| 2014-05-14 | XNPT | Option Ex | 5,000 | .00 | 0 |
| 2014-04-24 | XNPT | Sale | 2,500 | 4.30 | 10,750 |
| 2013-05-16 | XNPT | Option Ex | 5,000 | .00 | 0 |
| 2008-06-16 | XNPT | Sale | 12,500 | 42.05 | 525,600 |
| 2008-06-16 | XNPT | Option Ex | 12,500 | 12.86 | 160,750 |
Table 4. Insider trading of Anacor Pharmaceuticals Inc (ANAC) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-03-22 | ANAC | Sale | 37,500 | 60.17 | 2,256,487 |
| 2016-01-04 | ANAC | Sale | 2,533 | 112.09 | 283,936 |
| 2015-12-11 | ANAC | Sale | 20,000 | 117.19 | 2,343,760 |
| 2015-12-11 | ANAC | Option Ex | 20,000 | 13.21 | 264,100 |
| 2015-09-15 | ANAC | Sale | 20,000 | 139.83 | 2,796,680 |
| 2015-09-15 | ANAC | Option Ex | 20,000 | 5.16 | 103,100 |
| 2015-08-13 | ANAC | Option Ex | 20,000 | 5.11 | 102,200 |
| 2015-08-13 | ANAC | Sale | 20,000 | 137.97 | 2,759,300 |
| 2015-04-24 | ANAC | Sale | 25,000 | 65.50 | 1,637,575 |
| 2015-04-27 | ANAC | Sale | 25,000 | 61.71 | 1,542,650 |
| 2015-03-19 | ANAC | Sale | 37,500 | 56.07 | 2,102,662 |
| 2014-12-26 | ANAC | Sale | 25,000 | 30.82 | 770,500 |
Table 5. Insider trading of Allos Therapeutics Inc (ALTH) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-02-29 | ALTH | Sale | 21,163 | 1.52 | 32,231 |
| 2012-03-01 | ALTH | Sale | 21,532 | 1.48 | 31,824 |
| 2012-02-23 | ALTH | Sale | 9,100 | 1.56 | 14,196 |
| 2012-02-24 | ALTH | Sale | 4,350 | 1.55 | 6,742 |
| 2011-11-15 | ALTH | Sale | 31,817 | 1.46 | 46,516 |
| 2011-11-16 | ALTH | Sale | 450 | 1.43 | 643 |
| 2011-03-17 | ALTH | Option Ex | 2,500 | 3.14 | 7,850 |
| 2011-02-23 | ALTH | Sale | 9,193 | 3.25 | 29,877 |
| 2011-02-24 | ALTH | Sale | 4,255 | 3.12 | 13,292 |
| 2010-02-24 | ALTH | Sale | 7,362 | 7.58 | 55,767 |
| 2010-02-23 | ALTH | Sale | 4,304 | 7.51 | 32,331 |
| 2010-02-08 | ALTH | Sale | 32,580 | 7.00 | 228,092 |
| 2010-01-08 | ALTH | Sale | 65,160 | 7.00 | 456,120 |
| 2009-08-10 | ALTH | Option Ex | 342,000 | 3.14 | 1,073,880 |
| 2009-08-10 | ALTH | Sale | 342,000 | 8.24 | 2,819,448 |
| 2009-08-05 | ALTH | Option Ex | 8,000 | 3.14 | 25,120 |
| 2009-08-05 | ALTH | Sale | 8,000 | 8.14 | 65,152 |
| 2008-03-10 | ALTH | Sale | 34,400 | 5.38 | 185,106 |
| 2007-12-31 | ALTH | Buy | 5,000 | 3.89 | 19,465 |
| 2007-03-12 | ALTH | Sale | 23,625 | 6.45 | 152,452 |
| 2006-12-29 | ALTH | Buy | 2,500 | 3.05 | 7,627 |
| 2006-04-13 | ALTH | Buy | 5,000 | 2.94 | 14,700 |
Table 6. Insider trading of Jazz Pharmaceuticals Plc (JAZZ) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-08-05 | JAZZ | Sale | 1,450 | 154.00 | 223,300 |
| 2020-11-02 | JAZZ | Option Ex | 4,691 | .00 | 0 |
| 2020-11-04 | JAZZ | Sale | 4,691 | 149.21 | 699,920 |
| 2020-08-07 | JAZZ | Sale | 931 | 125.87 | 117,185 |
| 2019-08-09 | JAZZ | Sale | 726 | 135.65 | 98,481 |
| 2018-08-10 | JAZZ | Sale | 660 | 176.61 | 116,563 |
| 2017-08-11 | JAZZ | Sale | 662 | 143.25 | 94,828 |
| 2016-08-15 | JAZZ | Sale | 633 | 136.45 | 86,372 |
| 2015-08-10 | JAZZ | Sale | 801 | 181.67 | 145,518 |
| 2014-08-12 | JAZZ | Sale | 1,087 | 133.15 | 144,734 |
| 2013-08-13 | JAZZ | Sale | 1,070 | 81.86 | 87,590 |
| 2012-03-09 | JAZZ | Sale | 39,200 | 49.56 | 1,942,752 |
| 2012-01-11 | JAZZ | Option Ex | 55,000 | 16.94 | 931,535 |
Table 7. Insider trading of Cellectar Biosciences, Inc. (CLRB) by Berns Paul L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-04-20 | CLRB | Buy | 117,371 | 2.12 | 248,826 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Berns Paul L
(See Remarks of Neumora Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.